HEPION PHARMACEUTICALS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
HEPION PHARMACEUTICALS, INC. (HEPA) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-13
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $0.00.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-19 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-21 | |
| 2023-12-31 | $0.00 10-K · filed 2025-04-08 | $200.00K 10-K · filed 2024-04-16 |
| 2023-09-30 | $500.00K 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $800.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.70M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.50M 10-K · filed 2023-04-10 | |
| 2022-09-30 | $2.60M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.40M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $6.80M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $7.40M 10-K · filed 2022-04-08 | |
| 2021-09-30 | $10.40M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $14.30M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $5.20M 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |